Genetic Medicines for Rare Diseases
Krystal Biotech (krystalbio.com) scores 82 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, in the 80th percentile of 10984 Healthcare brands.
Krystal Biotech is a commercial-stage biotechnology company that develops gene therapies for patients with genetic, life-threatening, or rare diseases. It uses a proprietary HSV-1 based gene delivery platform to create redosable therapies, most notably VYJUVEK, the first and only redosable gene therapy for dystrophic epidermolysis bullosa. The company's work targets the underlying genetic causes of serious diseases, serving patients, healthcare providers, and investors interested in gene therapy innovation.
| Brand Name | Krystal Biotech |
|---|---|
| Domain | krystalbio.com |
| Industry | Healthcare |
| Main Competitors | Abeona Therapeutics, Chiesi Group (Filsuvez/Amryt) (86/100), Castle Creek Biosciences, uniQure, Sarepta Therapeutics (83/100), Ultragenyx Pharmaceutical (79/100), bluebird bio (57/100) |
Moz Domain Authority 44/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,124,305 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Krystal Biotech is a gene therapy biotechnology company focused on developing and delivering medicines to patients with genetic life-threatening or rare diseases using an HSV-1 bas…" (Meta description: 29 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram, GitHub; no detected presence on Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Krystal Biotech?", Claude could identify the brand as of September 2026. Krystal Biotech is a biotech company focused on developing gene therapies for rare skin and lung diseases, using its proprietary HSV-1 based gene delivery platform (STAR-D) to deliver functional genes directly to affected tissue. Best known for Vyjuvek (beremagene geperpavec), the first FDA-approved topical gene therapy for dystrophic epidermolysis bullosa (DEB).
When asked "Best brands similar to Krystal Biotech?", Claude would recommend Krystal Biotech as of September 2026. It's a notable player in gene therapy for rare genetic skin diseases with an approved commercial product, making it relevant when discussing leaders in that niche.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Krystal Biotech's main competitors in Healthcare: Chiesi Group (Filsuvez/Amryt) (86/100), Sarepta Therapeutics (83/100), Ultragenyx Pharmaceutical (79/100), bluebird bio (57/100).
Sources: Brand Analyzer scan
Krystal Biotech is a commercial-stage biotechnology company focused on developing and delivering genetic medicines for patients with life-threatening or rare diseases, using a proprietary HSV-1 based gene delivery platform.
Sources: Krystal Biotech official site
Krystal Biotech has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 52, recommendation 66). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Krystal Biotech official site
Krystal Biotech develops gene therapies designed to treat the root cause of genetic, life-threatening, or rare diseases. It uses an HSV-1 based delivery platform to create redosable therapies, meaning treatments can be administered repeatedly over time. Its lead commercial product, VYJUVEK, treats dystrophic epidermolysis bullosa, a genetic skin disorder.
Sources: Krystal Biotech official site
Krystal Biotech's primary product is VYJUVEK, a redosable gene therapy for dystrophic epidermolysis bullosa. The company also maintains a broader pipeline of genetic medicines built on its proprietary HSV-1 based gene delivery platform, targeting other genetic, life-threatening, or rare diseases.
Sources: Krystal Biotech official site
Krystal Biotech scores 66/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Krystal Biotech official site
Krystal Biotech is known for developing VYJUVEK, the first and only redosable gene therapy for dystrophic epidermolysis bullosa, using its proprietary HSV-1 based gene delivery platform.
Sources: Krystal Biotech official site
Krystal Biotech can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Krystal Biotech official site
Krystal Biotech's therapies are used by patients suffering from genetic, life-threatening, or rare diseases, such as dystrophic epidermolysis bullosa. Healthcare providers administer its treatments, and investors monitor the company as a commercial-stage biotechnology firm in the gene therapy sector.
Sources: Krystal Biotech official site
Krystal Biotech is notable within the gene therapy field for pioneering a redosable gene delivery platform based on HSV-1, and for bringing VYJUVEK to market as the first and only redosable gene therapy for dystrophic epidermolysis bullosa, a rare genetic skin disease.
Sources: Krystal Biotech official site
Krystal Biotech scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Krystal Biotech has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (66/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,124,305 (Tranco) and a Moz Domain Authority of 44/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Krystal Biotech from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Krystal Biotech: KritiKal (82/100), Kois Center (82/100), LandingAI (82/100), Lanserhof (82/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.